CITISINA: Un cambio di paradigma nel trattamento della dipendenza da nicotina?

Journal title MISSION
Author/s Linda Daffini
Publishing Year 2026 Issue 2026/74
Language Italian Pages 2 P. 71-72 File size 0 KB
DOI 10.3280/mis74-2026oa23195
DOI is like a bar code for intellectual property: to have more infomation click here

View article Download Open Access article

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

  1. Rigotti N.A., Benowitz N.L., Prochaska J.J., Rubinstein M., Clarke A., Blumenstein B., Cain D.F., & Jacobs C. (2025). Cytisinicline for Smoking Cessation: The ORCA Phase 3 Replication Randomized Clinical Trial. JAMA Intern Med., Jun 1, 185(6): 648-655. Doi: 10.1001/jamainternmed.2025.0628.
  2. Puljevic´ C., Stjepanovic´ D., Meciar I., Kang H., Chan G., Morphett K., Bendotti H., Kunwar G., & Gartner C. (2024). Systematic review and meta-analyses of cytisine to support tobacco cessation. Addiction, Oct, 119(10): 1713-1725. Doi: 10.1111/add.16592.

Linda Daffini, CITISINA: Un cambio di paradigma nel trattamento della dipendenza da nicotina? in "MISSION" 74/2026, pp 71-72, DOI: 10.3280/mis74-2026oa23195